Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Oliceridine by Trevena for Pain: Likelihood of Approval
Oliceridine is under clinical development by Trevena and currently in Phase II for Pain. According to GlobalData, Phase II drugs...
Data Insights
Oxycodone by MEDRx for Pain: Likelihood of Approval
Oxycodone is under clinical development by MEDRx and currently in Phase I for Pain. According to GlobalData, Phase I drugs...